Siglec-15 Silencing Inhibits Cell Proliferation and Promotes Cell Apoptosis by Inhibiting STAT1/STAT3 Signaling in Anaplastic Thyroid Carcinoma

Table 1

Correlation between Siglec-15 expression and clinicopathological characteristics in THCA patients.

Characteristics	Number	Siglec-15 expression			values
		Low ()	High ()
Type
FTC	16	7	9	15.885	0.001
PTC	26	21	5
Adenoma	13	4	9
ATC	31	10	21
Gender
Male	38	19	19	0.037	0.848
Female	48	23	25
Age (years)
≥65	37	20	17	0.707	0.400
<65	49	22	27
Tumor size (cm)
≤2	43	26	17	4.654	0.031
>2	43	16	27
Lymph nodes metastasis
No	60	28	32	0.374	0.541
Yes	26	14	12
Distant metastasis
No	42	29	13	13.420	<0.001
Yes	44	13	31

Note: THCA: thyroid cancer; FTC: follicular thyroid carcinoma; PTC: papillary thyroid carcinoma; ATC: anaplastic thyroid cancer. .